Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irving M Spitz

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Human Reproduction Update|March 26, 2005
Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applicationsNathalie Chabbert-Buffet, Geri Meduri, Philippe Bouchard, et al.
Human Reproduction (Oxford, England)|May 30, 2003
Management of a perforated levonorgestrel-medicated intrauterine device--a pharmacokinetic study: case reportRonit Haimov-Kochman, Hagay Amsalem, Amiram Adoni, et al.
The Journal of Urology|May 19, 2007
Is sildenafil citrate associated with an amelioration of the symptomatology of androgen decline in the aging male?Dmitry Koulikov, Alon Fridmans, Boris Chertin, et al.
Fertility and Sterility|December 20, 2005
Management of patients receiving long-term treatment with mifepristoneIrving M Spitz, Steven M Grunberg, Nathalie Chabbert-Buffet, et al.
The Israel Medical Association Journal : IMAJ|May 25, 2005
Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptomsAvraham Ben-Chetrit, Drorit Hochner-Celnikier, Tzina Lindenberg, et al.
The Journal of Urology|February 16, 2005
Reversibility of androgen deprivation therapy in patients with prostate cancerAlon Fridmans, Boris Chertin, Dmitry Koulikov, et al.
European Journal of Endocrinology|October 13, 2009
Relationships between FSH, inhibin B, anti-Mullerian hormone, and testosterone during long-term treatment with the GnRH-agonist histrelin in patients with prostate cancerTalia Eldar-Geva, Gad Liberty, Boris Chertin, et al.
Pediatrics|December 3, 2005
The histrelin implant: a novel treatment for central precocious pubertyHarry J Hirsch, David Gillis, David Strich, et al.
Cancer Investigation|December 13, 2006
Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningiomaSteven M Grunberg, Martin H Weiss, Christy A Russell, et al.
The Journal of Clinical Endocrinology and Metabolism|March 27, 2010
Free alpha-subunit is the most sensitive marker of gonadotropin recovery after treatment of central precocious puberty with the histrelin implantHarry J Hirsch, Najiba Lahlou, David Gillis, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Human Reproduction Update|March 26, 2005
Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applicationsNathalie Chabbert-Buffet, Geri Meduri, Philippe Bouchard, et al.
Human Reproduction (Oxford, England)|May 30, 2003
Management of a perforated levonorgestrel-medicated intrauterine device--a pharmacokinetic study: case reportRonit Haimov-Kochman, Hagay Amsalem, Amiram Adoni, et al.
The Journal of Urology|May 19, 2007
Is sildenafil citrate associated with an amelioration of the symptomatology of androgen decline in the aging male?Dmitry Koulikov, Alon Fridmans, Boris Chertin, et al.
Fertility and Sterility|December 20, 2005
Management of patients receiving long-term treatment with mifepristoneIrving M Spitz, Steven M Grunberg, Nathalie Chabbert-Buffet, et al.
The Israel Medical Association Journal : IMAJ|May 25, 2005
Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptomsAvraham Ben-Chetrit, Drorit Hochner-Celnikier, Tzina Lindenberg, et al.
The Journal of Urology|February 16, 2005
Reversibility of androgen deprivation therapy in patients with prostate cancerAlon Fridmans, Boris Chertin, Dmitry Koulikov, et al.
European Journal of Endocrinology|October 13, 2009
Relationships between FSH, inhibin B, anti-Mullerian hormone, and testosterone during long-term treatment with the GnRH-agonist histrelin in patients with prostate cancerTalia Eldar-Geva, Gad Liberty, Boris Chertin, et al.
Pediatrics|December 3, 2005
The histrelin implant: a novel treatment for central precocious pubertyHarry J Hirsch, David Gillis, David Strich, et al.
Cancer Investigation|December 13, 2006
Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningiomaSteven M Grunberg, Martin H Weiss, Christy A Russell, et al.
The Journal of Clinical Endocrinology and Metabolism|March 27, 2010
Free alpha-subunit is the most sensitive marker of gonadotropin recovery after treatment of central precocious puberty with the histrelin implantHarry J Hirsch, Najiba Lahlou, David Gillis, et al.
Pageof 3